Analyze Diet
Equine veterinary journal2016; 49(4); 532-538; doi: 10.1111/evj.12629

The preventive effects of two nutraceuticals on experimentally induced acute synovitis.

Abstract: Nutraceuticals are often used in the management of equine osteoarthritis, but scientific evidence of their efficacy is lacking. Objective: To study the preventive effects of two new nutraceuticals after the experimental induction of synovitis in comparison with positive and negative control treatments. Methods: Blinded, controlled, randomised experiment. Methods: Twenty-four healthy Standardbred horses were randomly allocated to supplement AT (multi-ingredient, 28 days), supplement HP (collagen hydrolysate, 60 days), meloxicam (4 days) or placebo (60 days). Synovitis was induced in the right intercarpal joint by intra-articular injection of 0.5 ng lipopolysaccharide (LPS) of Escherichia coli while treatments were continued. Blood and synovial fluid were sampled before treatment, immediately prior to LPS injection, and at 8, 24 and 48 h post-injection. Synovial fluid samples were analysed for total nucleated cell count (TNCC), total protein (TP) and selected biomarkers (prostaglandin E [PGE ], interleukin-6 [IL-6], glycosaminoglycans [GAGs], type II collagen synthesis [CPII], matrix metalloproteinase [MMP]). Lameness was scored by visual examination and pressure plate analysis immediately prior to LPS injection, and at 8, 24 and 48 h post-injection. Clinical examinations were performed before treatment, immediately prior to LPS injection, at 2, 4 and 6 h post-injection, and then twice per day during the test period. Results: Before treatment and intra-articular challenge, there were no statistically significant differences among the treatment groups for any of the parameters. After intra-articular challenge, the placebo group showed significantly higher synovial fluid TP, TNCC and PGE compared with the meloxicam group, although the model did not induce a relevant amount of lameness. Both nutraceuticals resulted in significantly lower synovial fluid TP, TNCC and PGE compared with placebo. No statistical differences in IL-6, GAGs, CPII or MMPs were observed among treatment groups. No adverse effects were observed. Conclusions: Despite evidence of synovitis, lameness was too mild to detect. Conclusions: The preventive administration of these nutraceuticals showed anti-inflammatory effects in this validated synovitis model. Therefore, further studies of their clinical applicability are warranted.
Publication Date: 2016-10-13 PubMed ID: 27554764PubMed Central: PMC5484312DOI: 10.1111/evj.12629Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

The research article explored the preventative impacts of two nutraceuticals on synovitis, a form of joint inflammation, in horses. Using an experimental model, it was found that the nutraceuticals seemed to exhibit anti-inflammatory effects.

Objective and Methodology

The study aimed to:

  • Evaluate the preventive effects of newly derived nutraceuticals on induced synovitis, benchmarking them against positive and negative control treatments.

The researchers conducted a blind, randomized, controlled experiment using 24 healthy Standardbred horses. The horses were divided into four groups, three of which received different treatments (AT supplement, HP supplement or meloxicam) and one group received a placebo.

These treatments aimed to test their impacts on synovitis, an inflammation in the joints, which was triggered in the right intercarpal joint of each horse by an injection of Escherichia coli lipopolysaccharide (LPS). Throughout the study duration, several variables like blood and synovial fluid, and lameness were monitored at different time points.

Results of Study

The study found:

  • Before the treatment and intra-articular challenge (injection of LPS to induce synovitis), there were no significant differences among groups with regard to any parameters under observation.
  • Following the injection, horses that received the placebo showed higher total protein (TP), total nucleated cell count (TNCC), and prostaglandin E (PGE) in the synovial fluid compared to those who received meloxicam.
  • Horses receiving nutraceuticals resulted in significantly lower TP, TNCC, and PGE in the synovial fluid as compared to placebo.
  • No significant differences noticed in interleukin-6, glycosaminoglycans, type II collagen synthesis or matrix metalloproteinase among different treatment groups.
  • All treatments could be administered without harmful effects.

Conclusion

In conclusion:

  • The study demonstrated that although there was evident synovitis, the induced lameness was too mild to detect. Therefore, the researchers conclude there’s room for further investigations using a more substantial model that captures clinically significant outcomes, like lameness.
  • The nutraceuticals under examination seemed to display anti-inflammatory effects on induced synovitis, laying the groundwork for future research to gauge their potential application clinically.

Cite This Article

APA
van de Water E, Oosterlinck M, Dumoulin M, Korthagen NM, van Weeren PR, van den Broek J, Everts H, Pille F, van Doorn DA. (2016). The preventive effects of two nutraceuticals on experimentally induced acute synovitis. Equine Vet J, 49(4), 532-538. https://doi.org/10.1111/evj.12629

Publication

ISSN: 2042-3306
NlmUniqueID: 0173320
Country: United States
Language: English
Volume: 49
Issue: 4
Pages: 532-538

Researcher Affiliations

van de Water, E
  • Department of Surgery and Anaesthesiology, Faculty of Veterinary Medicine, Ghent University, Belgium.
Oosterlinck, M
  • Department of Surgery and Anaesthesiology, Faculty of Veterinary Medicine, Ghent University, Belgium.
Dumoulin, M
  • Department of Surgery and Anaesthesiology, Faculty of Veterinary Medicine, Ghent University, Belgium.
Korthagen, N M
  • Department of Equine Sciences, Faculty of Veterinary Medicine, Utrecht University, The Netherlands.
van Weeren, P R
  • Department of Equine Sciences, Faculty of Veterinary Medicine, Utrecht University, The Netherlands.
van den Broek, J
  • Department of Farm Animal Health, Faculty of Veterinary Medicine, Utrecht University, The Netherlands.
Everts, H
  • Department of Farm Animal Health, Faculty of Veterinary Medicine, Utrecht University, The Netherlands.
Pille, F
  • Department of Surgery and Anaesthesiology, Faculty of Veterinary Medicine, Ghent University, Belgium.
van Doorn, D A
  • Department of Equine Sciences, Faculty of Veterinary Medicine, Utrecht University, The Netherlands.
  • Department of Farm Animal Health, Faculty of Veterinary Medicine, Utrecht University, The Netherlands.
  • Equivado, Equine Nutrition Consultancy, Utrecht, The Netherlands.

MeSH Terms

  • Animals
  • Anti-Inflammatory Agents, Non-Steroidal / pharmacology
  • Collagen / chemistry
  • Dietary Supplements
  • Horse Diseases / prevention & control
  • Horses
  • Interleukin-6
  • Meloxicam
  • Protein Hydrolysates / pharmacology
  • Synovial Fluid / chemistry
  • Synovitis / prevention & control
  • Synovitis / veterinary
  • Thiazines / pharmacology
  • Thiazoles / pharmacology

References

This article includes 38 references
  1. Neundorf RH, Lowerison MB, Cruz AM, Thomason JJ, McEwen BJ, Hurtig MB. Determination of the prevalence and severity of metacarpophalangeal joint osteoarthritis in Thoroughbred racehorses via quantitative macroscopic evaluation.. Am J Vet Res 2010 Nov;71(11):1284-93.
    pubmed: 21034319doi: 10.2460/ajvr.71.11.1284google scholar: lookup
  2. Trumble TN. The use of nutraceuticals for osteoarthritis in horses.. Vet Clin North Am Equine Pract 2005 Dec;21(3):575-97, v-vi.
    pubmed: 16297722doi: 10.1016/j.cveq.2005.08.004google scholar: lookup
  3. Brien S, Prescott P, Bashir N, Lewith H, Lewith G. Systematic review of the nutritional supplements dimethyl sulfoxide (DMSO) and methylsulfonylmethane (MSM) in the treatment of osteoarthritis.. Osteoarthritis Cartilage 2008 Nov;16(11):1277-88.
    pubmed: 18417375doi: 10.1016/j.joca.2008.03.002google scholar: lookup
  4. Pearson W, Lindinger M. Low quality of evidence for glucosamine-based nutraceuticals in equine joint disease: review of in vivo studies.. Equine Vet J 2009 Sep;41(7):706-12.
    pubmed: 19927591doi: 10.2746/042516409x424153google scholar: lookup
  5. Vandeweerd JM, Coisnon C, Clegg P, Cambier C, Pierson A, Hontoir F, Saegerman C, Gustin P, Buczinski S. Systematic review of efficacy of nutraceuticals to alleviate clinical signs of osteoarthritis.. J Vet Intern Med 2012 May-Jun;26(3):448-56.
  6. Orth MW, Peters TL, Hawkins JN. Inhibition of articular cartilage degradation by glucosamine-HCl and chondroitin sulphate.. Equine Vet J Suppl 2002 Sep;(34):224-9.
  7. Dechant JE, Baxter GM, Frisbie DD, Trotter GW, McIlwraith CW. Effects of glucosamine hydrochloride and chondroitin sulphate, alone and in combination, on normal and interleukin-1 conditioned equine articular cartilage explant metabolism.. Equine Vet J 2005 May;37(3):227-31.
    pubmed: 15892231doi: 10.2746/0425164054530687google scholar: lookup
  8. Neil KM, Orth MW, Coussens PM, Chan PS, Caron JP. Effects of glucosamine and chondroitin sulfate on mediators of osteoarthritis in cultured equine chondrocytes stimulated by use of recombinant equine interleukin-1beta.. Am J Vet Res 2005 Nov;66(11):1861-9.
    pubmed: 16334941doi: 10.2460/ajvr.2005.66.1861google scholar: lookup
  9. Chan PS, Caron JP, Rosa GJ, Orth MW. Glucosamine and chondroitin sulfate regulate gene expression and synthesis of nitric oxide and prostaglandin E(2) in articular cartilage explants.. Osteoarthritis Cartilage 2005 May;13(5):387-94.
    pubmed: 15882562doi: 10.1016/j.joca.2005.01.003google scholar: lookup
  10. Byron CR, Stewart MC, Stewart AA, Pondenis HC. Effects of clinically relevant concentrations of glucosamine on equine chondrocytes and synoviocytes in vitro.. Am J Vet Res 2008 Sep;69(9):1129-34.
    pubmed: 18764682doi: 10.2460/ajvr.69.9.1129google scholar: lookup
  11. Meulyzer M, Vachon P, Beaudry F, Vinardell T, Richard H, Beauchamp G, Laverty S. Comparison of pharmacokinetics of glucosamine and synovial fluid levels following administration of glucosamine sulphate or glucosamine hydrochloride.. Osteoarthritis Cartilage 2008 Sep;16(9):973-9.
    pubmed: 18295513doi: 10.1016/j.joca.2008.01.006google scholar: lookup
  12. Welch CA, Potter GD, Gibbs PG, Eller EM. Plasma concentration of glucosamine and chondroitin sulfate in horses after an oral dose. J. Equine. Vet. Sci. 2012;32:60-64.
  13. Gupta RC, Canerdy TD, Skaggs P, Stocker A, Zyrkowski G, Burke R, Wegford K, Goad JT, Rohde K, Barnett D, DeWees W, Bagchi M, Bagchi D. Therapeutic efficacy of undenatured type-II collagen (UC-II) in comparison to glucosamine and chondroitin in arthritic horses.. J Vet Pharmacol Ther 2009 Dec;32(6):577-84.
  14. Ebisuzaki K. Aspirin and methylsulfonylmethane (MSM): a search for common mechanisms, with implications for cancer prevention.. Anticancer Res 2003 Jan-Feb;23(1A):453-8.
    pubmed: 12680248
  15. Usha PR, Naidu MU. Randomised, Double-Blind, Parallel, Placebo-Controlled Study of Oral Glucosamine, Methylsulfonylmethane and their Combination in Osteoarthritis.. Clin Drug Investig 2004;24(6):353-63.
  16. Debbi EM, Agar G, Fichman G, Ziv YB, Kardosh R, Halperin N, Elbaz A, Beer Y, Debi R. Efficacy of methylsulfonylmethane supplementation on osteoarthritis of the knee: a randomized controlled study.. BMC Complement Altern Med 2011 Jun 27;11:50.
    pmc: PMC3141601pubmed: 21708034doi: 10.1186/1472-6882-11-50google scholar: lookup
  17. Marañón G, Muñoz-Escassi B, Manley W, García C, Cayado P, de la Muela MS, Olábarri B, León R, Vara E. The effect of methyl sulphonyl methane supplementation on biomarkers of oxidative stress in sport horses following jumping exercise.. Acta Vet Scand 2008 Nov 7;50(1):45.
    pmc: PMC2586020pubmed: 18992134doi: 10.1186/1751-0147-50-45google scholar: lookup
  18. Oesser S, Seifert J. Stimulation of type II collagen biosynthesis and secretion in bovine chondrocytes cultured with degraded collagen.. Cell Tissue Res 2003 Mar;311(3):393-9.
    pubmed: 12658447doi: 10.1007/s00441-003-0702-8google scholar: lookup
  19. Clark KL, Sebastianelli W, Flechsenhar KR, Aukermann DF, Meza F, Millard RL, Deitch JR, Sherbondy PS, Albert A. 24-Week study on the use of collagen hydrolysate as a dietary supplement in athletes with activity-related joint pain.. Curr Med Res Opin 2008 May;24(5):1485-96.
    pubmed: 18416885doi: 10.1185/030079908x291967google scholar: lookup
  20. Bruyère O, Zegels B, Leonori L, Rabenda V, Janssen A, Bourges C, Reginster JY. Effect of collagen hydrolysate in articular pain: a 6-month randomized, double-blind, placebo controlled study.. Complement Ther Med 2012 Jun;20(3):124-30.
    pubmed: 22500661doi: 10.1016/j.ctim.2011.12.007google scholar: lookup
  21. Coenen M, Appelt K, Niemeyer A, Vervuert I. Study of gelatin supplemented diet on amino acid homeostasis in the horse.. Equine Vet J Suppl 2006 Aug;(36):606-10.
  22. de Grauw JC, van de Lest CH, van Weeren PR. Inflammatory mediators and cartilage biomarkers in synovial fluid after a single inflammatory insult: a longitudinal experimental study.. Arthritis Res Ther 2009;11(2):R35.
    pmc: PMC2688180pubmed: 19272138doi: 10.1186/ar2640google scholar: lookup
  23. de Grauw JC, van de Lest CH, Brama PA, Rambags BP, van Weeren PR. In vivo effects of meloxicam on inflammatory mediators, MMP activity and cartilage biomarkers in equine joints with acute synovitis.. Equine Vet J 2009 Sep;41(7):693-9.
    pubmed: 19927589doi: 10.2746/042516409x436286google scholar: lookup
  24. Faul F, Erdfelder E, Buchner A, Lang AG. Statistical power analyses using G*Power 3.1: tests for correlation and regression analyses.. Behav Res Methods 2009 Nov;41(4):1149-60.
    pubmed: 19897823doi: 10.3758/brm.41.4.1149google scholar: lookup
  25. Pearson W, Orth MW, Lindinger MI. Evaluation of inflammatory responses induced via intra-articular injection of interleukin-1 in horses receiving a dietary nutraceutical and assessment of the clinical effects of long-term nutraceutical administration.. Am J Vet Res 2009 Jul;70(7):848-61.
    pubmed: 19566470doi: 10.2460/ajvr.70.7.848google scholar: lookup
  26. Centraal Veevoederbureau (2004) Het EWpa en VREp system. CVB documentation report no 31, CVB, Lelystad.
  27. Bassage II LH, Ross MW. Diagnostic analgesia. In: Diagnosis and Management of Lameness in the Horse, 2nd edn., Eds: Ross M.W. and Dyson S.J., Saunders Elsevier, London: pp 100-135.
  28. de Grauw JC, Brama PA, Wiemer P, Brommer H, van de Lest CH, van Weeren PR. Cartilage-derived biomarkers and lipid mediators of inflammation in horses with osteochondritis dissecans of the distal intermediate ridge of the tibia.. Am J Vet Res 2006 Jul;67(7):1156-62.
    pubmed: 16817736doi: 10.2460/ajvr.67.7.1156google scholar: lookup
  29. Laverty S, Ionescu M, Marcoux M, Bouré L, Doizé B, Poole AR. Alterations in cartilage type-II procollagen and aggrecan contents in synovial fluid in equine osteochondrosis.. J Orthop Res 2000 May;18(3):399-405.
    pubmed: 10937626doi: 10.1002/jor.1100180311google scholar: lookup
  30. Billinghurst RC, Brama PA, van Weeren PR, Knowlton MS, McIlwraith CW. Significant exercise-related changes in the serum levels of two biomarkers of collagen metabolism in young horses.. Osteoarthritis Cartilage 2003 Oct;11(10):760-9.
    pubmed: 13129696doi: 10.1016/s1063-4584(03)00152-3google scholar: lookup
  31. American Association of Equine Practitioners. Guide for Veterinary Service and Judging of Equestrian Events. 4th edn., AAEP, Lexington, Kentucky, 1991.
  32. Oosterlinck M, Pille F, Back W, Dewulf J, Gasthuys F. Use of a stand-alone pressure plate for the objective evaluation of forelimb symmetry in sound ponies at walk and trot.. Vet J 2010 Mar;183(3):305-9.
    pubmed: 19217810doi: 10.1016/j.tvjl.2008.12.012google scholar: lookup
  33. Burham KP, Anderson DR. Model Selection and Multimodel Inference: A Practical Information-Theoretic approach. 2nd edn., Springer Verlag, Berlin, 2002.
  34. Hanson RR, Smalley LR, Huff GK, White S, Hammad TA. Oral treatment with a glucosamine-chondroitin sulfate compound for degenerative joint disease in horses: 25 cases. Equine Pract. 1997;19:16-20.
  35. Cayzer J, Hedderley D, Gray S. A randomised, double-blinded, placebo-controlled study on the efficacy of a unique extract of green-lipped mussel (Perna canaliculus) in horses with chronic fetlock lameness attributed to osteoarthritis.. Equine Vet J 2012 Jul;44(4):393-8.
  36. Pearson W, Fletcher RS, Kott LS. Oral rosmarinic acid-enhanced Mentha spicata modulates synovial fluid biomarkers of inflammation in horses challenged with intra-articular LPS.. J Vet Pharmacol Ther 2012 Oct;35(5):495-502.
  37. Smith MD, Triantafillou S, Parker A, Youssef PP, Coleman M. Synovial membrane inflammation and cytokine production in patients with early osteoarthritis.. J Rheumatol 1997 Feb;24(2):365-71.
    pubmed: 9034998
  38. Benito MJ, Veale DJ, FitzGerald O, van den Berg WB, Bresnihan B. Synovial tissue inflammation in early and late osteoarthritis.. Ann Rheum Dis 2005 Sep;64(9):1263-7.
    pmc: PMC1755629pubmed: 15731292doi: 10.1136/ard.2004.025270google scholar: lookup

Citations

This article has been cited 12 times.
  1. Elango J, Zamora-Ledezma C, Ge B, Hou C, Pan Z, Bao B, Pérez Albacete Martínez C, Granero Marín JM, de Val JEMS, Bao C, Wu W. Paradoxical Duel Role of Collagen in Rheumatoid Arthritis: Cause of Inflammation and Treatment. Bioengineering (Basel) 2022 Jul 15;9(7).
    doi: 10.3390/bioengineering9070321pubmed: 35877372google scholar: lookup
  2. Yamada ALM, do Prado Vendruscolo C, Marsiglia MF, Sotelo EDP, Agreste FR, Seidel SRT, Fülber J, Baccarin RYA, da Silva LCLC. Effects of oral treatment with chondroitin sulfate and glucosamine in an experimental model of metacarpophalangeal osteoarthritis in horses. BMC Vet Res 2022 Jun 9;18(1):215.
    doi: 10.1186/s12917-022-03323-3pubmed: 35681208google scholar: lookup
  3. Yuan Z, Liu S, Song W, Liu Y, Bi G, Xie R, Ren L. Galactose Enhances Chondrogenic Differentiation of ATDC5 and Cartilage Matrix Formation by Chondrocytes. Front Mol Biosci 2022;9:850778.
    doi: 10.3389/fmolb.2022.850778pubmed: 35615738google scholar: lookup
  4. Clarke EJ, Gillen A, Turlo A, Peffers MJ. An Evaluation of Current Preventative Measures Used in Equine Practice to Maintain Distal Forelimb Functionality: A Mini Review. Front Vet Sci 2021;8:758970.
    doi: 10.3389/fvets.2021.758970pubmed: 34796229google scholar: lookup
  5. Mobasheri A, Mahmoudian A, Kalvaityte U, Uzieliene I, Larder CE, Iskandar MM, Kubow S, Hamdan PC, de Almeida CS Jr, Favazzo LJ, van Loon LJC, Emans PJ, Plapler PG, Zuscik MJ. A White Paper on Collagen Hydrolyzates and Ultrahydrolyzates: Potential Supplements to Support Joint Health in Osteoarthritis?. Curr Rheumatol Rep 2021 Oct 30;23(11):78.
    doi: 10.1007/s11926-021-01042-6pubmed: 34716494google scholar: lookup
  6. Menarim BC, Gillis KH, Oliver A, Ngo Y, Werre SR, Barrett SH, Rodgerson DH, Dahlgren LA. Macrophage Activation in the Synovium of Healthy and Osteoarthritic Equine Joints. Front Vet Sci 2020;7:568756.
    doi: 10.3389/fvets.2020.568756pubmed: 33324696google scholar: lookup
  7. Much ML, Leatherwood JL, Martinez RE, Silvers BL, Basta CF, Gray LF, Bradbery AN. Evaluation of an oral joint supplement on gait kinematics and biomarkers of cartilage metabolism and inflammation in mature riding horses. Transl Anim Sci 2020 Jul;4(3):txaa150.
    doi: 10.1093/tas/txaa150pubmed: 32968713google scholar: lookup
  8. Faramarzi B, Nguyen A, Dong F. Changes in hoof kinetics and kinematics at walk in response to hoof trimming: pressure plate assessment. J Vet Sci 2018 Jul 31;19(4):557-562.
    doi: 10.4142/jvs.2018.19.4.557pubmed: 29486539google scholar: lookup
  9. Kranenburg LC, Reinke KS, van den Broek J, Zaal EA, van den Boom R, van Doorn DA. Free Plasma Amino Acid Concentrations in Horses Fed Different Dosing Regimens of Hydrolysed Collagen. Animals (Basel) 2025 Nov 3;15(21).
    doi: 10.3390/ani15213195pubmed: 41227525google scholar: lookup
  10. Duggan MJS, Kearney C, Baltrimaite M, Labberté MC, Gibney R, Brama PAJ. Refinement of the Lipopolysaccharide-Induced Synovitis Model in Equine Middle Carpal Joints. Animals (Basel) 2025 Aug 22;15(17).
    doi: 10.3390/ani15172474pubmed: 40941269google scholar: lookup
  11. Varela L, van de Lest CHA, van Weeren PR, Wauben MHM. Synovial fluid extracellular vesicles as arthritis biomarkers: the added value of lipid-profiling and integrated omics. Extracell Vesicles Circ Nucl Acids 2024;5(2):276-296.
    doi: 10.20517/evcna.2024.14pubmed: 39698533google scholar: lookup
  12. de Carvalho JRG, Del Puppo D, Littiere TO, de Sales NAA, Silva ACY, Ribeiro G, de Almeida FN, Alves BG, Gatto IRH, Ramos GV, Ferraz GC. Functional infrared thermography imaging can be used to assess the effectiveness of Maxicam Gel(®) in pre-emptively treating transient synovitis and lameness in horses. Front Vet Sci 2024;11:1399815.
    doi: 10.3389/fvets.2024.1399815pubmed: 38919154google scholar: lookup